1. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis;Ramsay;N Engl J Med,1999
2. Aerosolised antibiotics: a critical appraisal of their use;Hagermann;Expert Opin Drug Deliv,2006
3. Standardisation of spirometry;Miller;Eur Respir J,2005
4. A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI;Griese;J Aerosol Med Pulm Drug Deliv,2013
5. Pharmacokinetics of tobramycin nebulizer solution 300mg/4ml (Bramitob(r)) administered by Pari eFlow(r) rapid vs. Pari LC(r) Plus nebulizer in cystic fibrosis patients;Govoni;Respir Drug Deliv,2012